Matters Of Communication: Handelsblatting The Oxford-AstraZeneca Vaccine – OpEd

The Oxford-AstraZeneca COVID-19 vaccine is fast becoming a subject of notoriety.  First, will States obtain it?  Second, will they use it?  The first answer has generally been affirmative, given the vaccine’s ease of storage and relative cheapness.  The second is becoming increasingly difficult. 

Orders have been made...